Uncover key drivers, emerging technologies, and competitive movements shaping the artificial intelligence (ai) in biopharmaceuticals market from 2025–2034 with trusted insights from The Business Research Company
How Will The Artificial Intelligence (AI) In Biopharmaceuticals Market Size Evolve Between Now And 2029?
The artificial intelligence (AI) in biopharmaceuticals market size has experienced significant expansion in recent years. This market is forecast to grow from $1.59 billion in 2024 to $2.1 billion in 2025, at a compound annual growth rate (CAGR) of 32.2%. Historically, this growth can be attributed to advancements in computational power, biomedical data explosion, the precision medicine paradigm, and regulatory support and guidance.
The artificial intelligence (AI) in biopharmaceuticals market is anticipated to experience substantial growth over the upcoming years. It is projected to expand to $6.58 billion by 2029, achieving a compound annual growth rate (CAGR) of 33.0%. This expansion during the forecast period is largely due to advancements in computational biology, integration of multi-modal data, convergence of AI and life sciences, regulatory support and frameworks, and ethical and fair AI principles. Significant trends expected in the forecast period comprise integration of multi-omics data, AI-driven drug design and discovery, explainable AI and regulatory acceptance, technological advancements, regulatory developments, and emerging opportunities.
Access A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14251&type=smp
Which Key Drivers Are Powering Growth In The Artificial Intelligence (AI) In Biopharmaceuticals Market?
The increasing occurrence of chronic illnesses is anticipated to boost the expansion of the artificial intelligence (AI) in biopharmaceuticals market in the future. These are enduring health conditions that typically advance gradually and can last for extended periods or an entire life. Their origins stem from elements such as lifestyle choices, a progressively older demographic, inherited susceptibilities, and environmental influences. Artificial intelligence (AI) in biopharmaceuticals finds increasing application in the management of chronic diseases due to its capability to analyze extensive volumes of varied data, pinpoint recurring patterns, and tailor treatment strategies. As an illustration, in November 2023, data from the Department of Health and Human Services, a US-based government entity, indicated an 11 percent rise in newly documented chronic hepatitis B cases in 2022 when contrasted with figures from 2021. Consequently, the expanding occurrence of chronic illnesses acts as a key catalyst for the growth of the artificial intelligence (AI) in biopharmaceuticals market.
How Is The Global Artificial Intelligence (AI) In Biopharmaceuticals Market Structured By Key Segments?
The artificial intelligence (ai) in biopharmaceuticals market covered in this report is segmented –
1) By Offering: Hardware, Software, Services
2) By Deployment: Cloud, On-Premises
3) By Technology: Machine Learning, Natural Language Processing, Deep Learning, Other Technologies
4) By Application: Business Process And Supply Chain, Drug Discovery, Medical Imaging And Diagnostics, Precision Medicine
5) By End-Users: Manufacturers, Contract Research Organizations, Academic And Government Research Institutes
Subsegments:
1) By Hardware: High-Performance Computing Systems, AI-Enabled Laboratory Equipment, Data Storage Solutions
2) By Software: Drug Discovery Platforms, Clinical Trial Management Software, Predictive Analytics Tools, Natural Language Processing Solutions
3) By Services: Consulting Services, Implementation And Integration Services, Data Management And Analytics Services, Training And Support Services
What Future-Focused Trends Are Anticipated In The Artificial Intelligence (AI) In Biopharmaceuticals Market?
Major artificial intelligence (AI) companies active in biopharmaceuticals are concentrating on developing innovative advancements, such as AI-powered target and lead identification suite solutions, to accelerate drug discovery and precision medicine and thereby transform life sciences organizations. These solutions for drug discovery and precision medicine involve various innovative methods for creating new drugs and customizing treatments for individual patients. For example, in May 2023, Google LLC, a US-based provider of cloud computing services, introduced two new AI-powered tools named target and lead identification suites, engineered to assist researchers in predicting and understanding protein structures, a foundational component of drug development. Additionally, this suite will support researchers in ingesting, storing, analyzing, and sharing large volumes of genomic data, which is essential for precision medicine. These tools also aim to streamline the drug discovery process, cut costs, and expedite the market launch of new treatments. By offering efficient data management, accurate protein structure predictions, and advanced genomic analysis capabilities, these tools seek to revolutionize drug development processes and improve patient outcomes.
Which Companies Hold A Competitive Edge In The Artificial Intelligence (AI) In Biopharmaceuticals Market?
Major companies operating in the artificial intelligence (AI) in biopharmaceuticals market are Apple Inc., Google LLC, Microsoft Corporation, Tencent Holdings Limited, Amazon Web Services Inc., International Business Machines Corporation, Exscientia Limited, NVIDIA Corporation, Amgen Inc., DeepMind Technologies Limited, Schrödinger Inc., XtalPi Inc., ConcertAI Inc., Insilico Medicine Inc., Recursion Pharmaceuticals, BenevolentAI, BioXcel Therapeutics, Atomwise Inc., BioAge Labs Inc., GNS Healthcare, Berg Health, Deep 6 AI Inc., Cloud Pharmaceuticals Inc., Numerate Inc., AI Therapeutics, Envisagenics, twoXAR Inc., Cyclica Inc.
Download The Full Report Here:
Which Region Is Expected To Lead The Artificial Intelligence (AI) In Biopharmaceuticals Market In The Next Few Years?
North America was the largest region in the artificial intelligence (AI) in biopharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in biopharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get A Report Customized For You Here:
https://www.thebusinessresearchcompany.com/customise?id=14251&type=smp
Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In Biopharmaceuticals Market 2025, By The Business Research Company
Artificial Intelligence Ai In Agriculture Global Market Report 2025
Artificial Intelligence In Cancer Diagnostics Global Market Report 2025
Artificial Intelligence In Cardiology Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model